C. Fletcher, The evolving classification of soft tissue tumours: an update based on the new WHO classification, Histopathology, vol.8, issue.1, pp.3-12, 2006.
DOI : 10.1097/00000478-200111000-00002

C. Gengler and L. Guillou, Solitary fibrous tumour and haemangiopericytoma: evolution of a concept, Histopathology, vol.447, issue.1, pp.63-74, 2006.
DOI : 10.1097/00000478-199711000-00010

R. Brunnemann, J. Ro, N. Ordonez, J. Mooney, A. Naggar et al., Extrapleural solitary fibrous tumor: a clinicopathologic study of 24 cases, Mod Pathol, vol.12, pp.1034-1042, 1999.

M. Park and D. Araujo, New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of tumors, Current Opinion in Oncology, vol.21, issue.4, pp.327-331, 2009.
DOI : 10.1097/CCO.0b013e32832c9532

J. Gold, C. Antonescu, C. Hajdu, C. Ferrone, M. Hussain et al., Clinicopathologic correlates of solitary fibrous tumors, Cancer, vol.69, issue.4, pp.1057-1068, 2002.
DOI : 10.1002/cncr.10328

D. England, L. Hochholzer, and M. Mccarthy, Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases

F. Spitz, M. Bouvet, P. Pisters, R. Pollock, and B. Feig, Hemangiopericytoma: A 20-year single-institution experience, Annals of Surgical Oncology, vol.214, issue.4, pp.350-355, 1998.
DOI : 10.1007/BF02303499

P. Magdeleinat, M. Alifano, A. Petino, L. Rochais, J. Dulmet et al., Solitary fibrous tumors of the pleura: clinical characteristics, surgical treatment and outcome, European Journal of Cardio-Thoracic Surgery, vol.21, issue.6, pp.1087-1093, 2002.
DOI : 10.1016/S1010-7940(02)00099-4

A. Constantinidou, R. Jones, D. Olmos, K. Thway, C. Fisher et al., Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour, Acta Oncologica, vol.151, issue.4, pp.550-554, 2012.
DOI : 10.1200/JCO.2008.21.3223

E. Galanis, J. Buckner, B. Scheithauer, D. Kimmel, P. Schomberg et al., Management of recurrent meningeal hemangiopericytoma, Cancer, vol.21, issue.10, pp.1915-1920, 1998.
DOI : 10.1002/(SICI)1097-0142(19980515)82:10<1915::AID-CNCR15>3.0.CO;2-W

L. Chaigneau, E. Kalbacher, A. Thiery-vuillemin, C. Fagnoni-legat, N. Isambert et al., Efficacy of trabectedin in metastatic solitary fibrous tumor, Rare Tumors, vol.3, issue.3, p.29, 2011.
DOI : 10.4081/rt.2011.e29

H. Choi, C. Charnsangavej, S. Faria, H. Macapinlac, M. Burgess et al., Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria, Journal of Clinical Oncology, vol.25, issue.13, pp.1753-1759, 2007.
DOI : 10.1200/JCO.2006.07.3049

M. Park, S. Patel, J. Ludwig, J. Trent, C. Conrad et al., Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor, Cancer, vol.27, issue.suppl, pp.4939-4947, 2011.
DOI : 10.1002/cncr.26098

J. Domont, C. Massard, N. Lassau, J. Armand, C. Le et al., Hemangiopericytoma and antiangiogenic therapy: clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed Malignant Haemangioperyctoma /Solitary Fibrous Tumour, Investigational New Drugs, vol.18, issue.4, pp.199-202, 2010.
DOI : 10.1007/s10637-009-9249-1

I. De, E. Grande-pulido, A. Bero-tamarit, and M. De-villena, Cancer and immune response: old and new evidence for future challenges, Oncologist, vol.13, pp.1246-1254, 2008.

P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan et al., New Guidelines to Evaluate the Response to Treatment in Solid Tumors, JNCI: Journal of the National Cancer Institute, vol.92, issue.3, pp.205-216, 2000.
DOI : 10.1093/jnci/92.3.205

S. Stacchiotti, T. Negri, M. Libertini, E. Palassini, A. Marrari et al., Sunitinib malate in solitary fibrous tumor (SFT), Annals of Oncology, vol.23, issue.12, pp.3171-3179, 2012.
DOI : 10.1093/annonc/mds143

S. George, J. Blay, P. Casali, C. Le, P. Stephenson et al., Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure, European Journal of Cancer, vol.45, issue.11
DOI : 10.1016/j.ejca.2009.02.011

M. Park, V. Ravi, and D. Araujo, Inhibiting the VEGF???VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor, Current Opinion in Oncology, vol.22, issue.4, pp.351-355, 2010.
DOI : 10.1097/CCO.0b013e32833aaad4

C. Chevreau, L. Cesne, A. Ray-coquard, I. Bui-nguyen, B. Bompas et al., Phase II study of sorafenib mesylate (So) in patients (pts) with evolutive and advanced epithelioid hemangioendothelioma (EHE) or hemangiopericytoma/solitary fibrous tumor (SFT), J Clin Oncol, vol.30, p.10020, 2012.